David L. Bilhartz
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Immunology top 5%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- Charles Y.F. YoungBenjamin T. MontgomeryPaul E. AndrewsL. Michael GlodéThomas SchuetzPhilip W. KantoffDonald J. TindallWayne R. Godfrey
- Topics
- Prostate Cancer Treatment and Research (9 papers)Prostate Cancer Diagnosis and Treatment (5 papers)Sexual function and dysfunction studies (4 papers)
- Journals
- Journal of Clinical OncologyBiochemical and Biophysical Research CommunicationsThe Journal of Urology
- Partner nations
- United States
In The Last Decade
David L. Bilhartz
18 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Pulmonary and Respiratory Medicine 1.2k
- Oncology 741
- Immunology 524
- Molecular Biology 432
- Cancer Research 307
Countries citing papers authored by David L. Bilhartz
This map shows the geographic impact of David L. Bilhartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Bilhartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Bilhartz more than expected).
Fields of papers citing papers by David L. Bilhartz
This network shows the impact of papers produced by David L. Bilhartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Bilhartz. The network helps show where David L. Bilhartz may publish in the future.
Co-authorship network of co-authors of David L. Bilhartz
This figure shows the co-authorship network connecting the top 25 collaborators of David L. Bilhartz. A scholar is included among the top collaborators of David L. Bilhartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Bilhartz. David L. Bilhartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancerbreakdown → | 727 |
| 2 | 2 | |
| 3 | 23 | |
| 4 | 377 | |
| 5 | 35 | |
| 6 | 16 | |
| 7 | 19 | |
| 8 | 15 | |
| 9 | 11 | |
| 10 | 40 | |
| 11 | 7 | |
| 12 | 18 | |
| 13 | 163 | |
| 14 | 33 | |
| 15 | Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. | 235 |
| 16 | 111 | |
| 17 | 76 | |
| 18 | 88 |
About David L. Bilhartz
David L. Bilhartz is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 2.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Sexual function and dysfunction studies (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Oncology (741 citations) and Immunology (524 citations). David L. Bilhartz has collaborated with scholars based in United States. Frequent co-authors include Charles Y.F. Young, Benjamin T. Montgomery, Paul E. Andrews, L. Michael Glodé, Thomas Schuetz, Philip W. Kantoff, Donald J. Tindall, Wayne R. Godfrey, William L. Dahut and Michael S. Wyand. Their work appears in journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.